Aksia Group has acquired a 75% stake in Medical International Research (MIR), a specialist in spirometry, oximetry and telemedicine.
A highlight of deal processes underway and involving PE, either on the buy- or sell-side, across Europe
Markus Dränert will focus on software and technology investments, joining from his role at Finleap
Frank-Noël Vandenberghe exits the business he co-founded with Michele Mezzarobba, who left last year
Investor's €360m fund has an extra capacity of €150m from the GP's listed vehicle and will focus on carve-outs